Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychi... Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy. Mostrar mais
Pergunte à ADVFN Intelligence (IA)
| Período | Var | Var % | Abe | Máx. | Mín. | Vol Méd. | VWAP diário | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0269 | 8.96367877374 | 0.3001 | 0.46 | 0.2603 | 13068774 | 0.37970975 | CS |
| 4 | -1.403 | -81.098265896 | 1.73 | 1.96 | 0.2603 | 6038212 | 0.43232386 | CS |
| 12 | -0.923 | -73.84 | 1.25 | 1.97 | 0.2603 | 2408991 | 0.60403305 | CS |
| 26 | -1.073 | -76.6428571429 | 1.4 | 1.97 | 0.2603 | 1622001 | 0.84720588 | CS |
| 52 | -6.583 | -95.2677279305 | 6.91 | 11.26 | 0.2603 | 1372477 | 2.14541066 | CS |
| 156 | -11.183 | -97.1589921807 | 11.51 | 13.15 | 0.2603 | 763237 | 4.34232206 | CS |
| 260 | -0.853 | -72.2881355932 | 1.18 | 20.04 | 0.2603 | 1075580 | 4.22925223 | CS |
Suporte: (11) 4950 5808 | suporte@advfn.com.br
Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições
Recursos principais
Premium
